Molecular basis of Glanzmann's Thrombasthenia and current strategies in treatment
- 5 August 2002
- journal article
- review article
- Published by Elsevier in Blood Reviews
- Vol. 16 (3) , 193-202
- https://doi.org/10.1016/s0268-960x(02)00030-9
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Missense mutations in the β3 subunit have a different impact on the expression and function between αIIbβ3 and αvβ3Blood, 2002
- A 1063GA mutation in exon 12 of glycoprotein (GP)IIb associated with a thrombasthenic phenotype: mutation analysis of [324E]GPIIbBritish Journal of Haematology, 2000
- A novel (288delC) mutation in exon 2 of GPIIb associated with type I Glanzmann's thrombastheniaBritish Journal of Haematology, 2000
- Homozygous Cys542→Arg substitution in GPIIIa in a Swiss patient with type I Glanzmann's thrombastheniaBritish Journal of Haematology, 1999
- Truncation of the cytoplasmic domain of beta3 in a variant form of Glanzmann thrombasthenia abrogates signaling through the integrin alpha(IIb)beta3 complex.Journal of Clinical Investigation, 1997
- Glanzmann thrombasthenia. Cooperation between sequence variants in cis during splice site selection.Journal of Clinical Investigation, 1996
- Dissecting Clot Retraction and Platelet AggregationPublished by Elsevier ,1996
- A second case of variant of Glanzmann's thrombasthenia due to substitution of platelet GPIII (integrinβ3) Arg214 by TrpHuman Molecular Genetics, 1993
- A new variant of Glanzmann's thrombasthenia (Strasbourg I). Platelets with functionally defective glycoprotein IIb-IIIa complexes and a glycoprotein IIIa 214Arg----214Trp mutation.Journal of Clinical Investigation, 1992
- Platelet Aggregation Is Not Necessary for Occurrence of Raynaud's Phenomenon: A Clinical History and Laboratory ResultsAngiology, 1990